Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
Submitted by
admin
on October 19, 2012 - 11:21am
Source:
Yahoo/AP
News Tags:
Isis Pharmaceuticals
FDA
advisory panels
Kynamro
Headline:
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
Do Not Allow Advertisers to Use My Personal information
